These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 903323

  • 1. Studies on cinoxacin. 1. In vitro activity of cinoxacin, as compared to nalidixic acid, against urinary tract pathogens.
    Mårdh PA, Collen S, Andersson KE.
    J Antimicrob Chemother; 1977 Sep; 3(5):411-6. PubMed ID: 903323
    [No Abstract] [Full Text] [Related]

  • 2. Comparative in vitro activity of norfloxacin and seven other antimicrobial agents against clinical isolates from urinary tract infections.
    Esko E, Renkonen OV.
    Scand J Infect Dis; 1985 Sep; 17(1):95-8. PubMed ID: 3158071
    [Abstract] [Full Text] [Related]

  • 3. In vitro antimicrobial activity of cinoxacin against 2,968 clinical bacterial isolates.
    Jones RN, Fuchs PC.
    Antimicrob Agents Chemother; 1976 Jul; 10(1):146-9. PubMed ID: 984747
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparative in-vitro activity of norfloxacin and selected antimicrobial agents against urinary tract pathogens and Neisseria gonorrhoeae.
    Sweet RL, Ohm-Smith MJ, Hadley WK.
    J Antimicrob Chemother; 1982 Dec; 10(6):553-7. PubMed ID: 6219085
    [No Abstract] [Full Text] [Related]

  • 6. Comparative study using norfloxacin and amoxycillin in the treatment of complicated urinary tract infections in geriatric patients.
    Leigh DA, Smith EC, Marriner J.
    J Antimicrob Chemother; 1984 May; 13 Suppl B():79-83. PubMed ID: 6234279
    [Abstract] [Full Text] [Related]

  • 7. In vitro synergistic activity of some chinolinic compounds combined with beta-lactam antibiotics against gram-positive and gram-negative clinical isolates.
    Ravagnan G, Piccolomini R, Speciale AM, Russo G, Renzini G.
    Chemotherapy; 1985 May; 31(3):191-9. PubMed ID: 3996087
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cinoxacin: in vitro antibacterial studies of a new synthetic organic acid.
    Lumish RM, Norden CW.
    Antimicrob Agents Chemother; 1975 Feb; 7(2):159-63. PubMed ID: 1094949
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparative in vitro activity of norfloxacin (MK-0366) and ten other oral antimicrobial agents against urinary bacterial isolates.
    Khan MY, Gruninger RP, Nelson SM, Klicker RE.
    Antimicrob Agents Chemother; 1982 May; 21(5):848-51. PubMed ID: 6213200
    [Abstract] [Full Text] [Related]

  • 12. [Therapy of urinary tract infections: striking Gram-negative germs. Changes in the bacterial spectrum and resistance in a group of patients over an 18-year period].
    Gussmann S.
    Fortschr Med; 1983 Sep 22; 101(36):1626-9. PubMed ID: 6629294
    [No Abstract] [Full Text] [Related]

  • 13. Bactericidal activity of norfloxacin and nine other urinary tract antibiotics against Gram-negative bacilli causing bacteriuria in chronically catheterized patients.
    Tenney JH, Warren JW.
    J Antimicrob Chemother; 1983 Mar 22; 11(3):287-90. PubMed ID: 6221010
    [Abstract] [Full Text] [Related]

  • 14. Study of the in vitro activity of norfloxacin and other drugs on amoxicillin-resistant uropathogenic isolates.
    Piccolomini R, Allocati N, Catamo G.
    Chemioterapia; 1984 Jun 22; 3(3):167-72. PubMed ID: 6241505
    [Abstract] [Full Text] [Related]

  • 15. Comparative in vitro studies of cinoxacin, nalidixic acid, and oxolinic acid.
    Gordon RC, Stevens LI, Edmiston CE, Mohan K.
    Antimicrob Agents Chemother; 1976 Dec 22; 10(6):918-20. PubMed ID: 12717
    [Abstract] [Full Text] [Related]

  • 16. [Nitrofurans: a modern treatment for uncomplicated urinary infections?].
    Cahen P, Honderlick P.
    Pathol Biol (Paris); 2000 Jun 22; 48(5):470-1. PubMed ID: 10949843
    [Abstract] [Full Text] [Related]

  • 17. Comparative in vitro activity of norfloxacin and four other chemotherapeutics against urinary gram-negative isolates.
    Esposito S, Galante D, Pennucci C, Barba D, Limauro D, Scioli C.
    Chemioterapia; 1984 Jun 22; 3(3):196-9. PubMed ID: 6241506
    [Abstract] [Full Text] [Related]

  • 18. Cinoxacin and nalidixic acid in treatment of urinary tract infections.
    Drylie DM.
    Urology; 1981 May 22; 17(5):500-1. PubMed ID: 7233672
    [No Abstract] [Full Text] [Related]

  • 19. The antimicrobial spectrum of norfloxacin.
    Newsom SW.
    J Antimicrob Chemother; 1984 May 22; 13 Suppl B():25-31. PubMed ID: 6234272
    [Abstract] [Full Text] [Related]

  • 20. ["In vitro" and "in vivo" antibacterial activity of a new synthetic antibiotic cinoxacin].
    Ravagnan G, Piccolomini R.
    Boll Soc Ital Biol Sper; 1979 Jul 30; 55(14):1348-54. PubMed ID: 391252
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.